High Prevalence of Pantoea in Diaphorina citri (Hemiptera: Liviidae): Vector of Citrus Huanglongbing Disease

Güz N., Arshad M., Cagatay N. S., Dageri A.

CURRENT MICROBIOLOGY, cilt.77, sa.8, ss.1525-1531, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 77 Sayı: 8
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1007/s00284-020-01969-6
  • Dergi Adı: CURRENT MICROBIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, Aquatic Science & Fisheries Abstracts (ASFA), BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, Environment Index, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.1525-1531
  • Ankara Üniversitesi Adresli: Evet

Özet

As an important insect vector, Asian citrus psyllid (ACP), Diaphorina citri Kuwayama (Hemiptera: Liviidae) transmits the pathogen 'Candidatus Liberibacter asiaticus' (CLas) that is associated with citrus greening also known as Huanglongbing (HLB) disease. The bacterial endosymbionts have a potential role in shaping the host range of insect herbivores and their performance on different host plants, which might affect the endosymbiont distribution in insect populations. Here, we detected and characterized Pantoea endosymbiont in nymph and adult ACP specimens collected from Citrus reticulata Blanco and Cordia myxa L. plants. The phylogenetic tree constructed using endosymbiotic bacteria 16S ribosomal RNA sequences indicated that Pantoea sp. was closely related to Mixta calida, sharing about 98% identity and was grouped with other Mixta and Pantoea endosymbionts. Our findings showed 100% and 92.3% infection of Pantoea in adults while 61.5% and 90% infection of Pantoea in nymphs collected from C. reticulata and C. myxa plants, respectively. Understanding the interaction of endosymbiotic bacteria with ACP associated with host plants could be useful for developing an effective management strategy for both ACP and HLB disease.